Anti-hypertensive
drugs are used to treat hypertension (high blood pressure). Hypertension is a
state of chronic elevated arterial blood pressure at or greater than 140/90 mm
Hg for adults.
The global anti-hypertensive drugs market was valued at $32.2 billion in 2015, and is expected to reach $ 38.9 billion by 2022. Thus the market is expected to perform sluggish growth at a CAGR of 2.73% from 2016 to 2022.
The global anti-hypertensive drugs market was valued at $32.2 billion in 2015, and is expected to reach $ 38.9 billion by 2022. Thus the market is expected to perform sluggish growth at a CAGR of 2.73% from 2016 to 2022.
There exact cause of essential hypertension is unknown but is
blamed on unhealthy lifestyle and ageing. The major market driving factor
for secondary hypertension are greater detection and early diagnosis. Rise in
the prevalence diseases such as kidney problems, thyroid problems, adrenal
gland tumors, heart ailments, chronic alcohol use etc. in which
anti-hypertensive are used are some of the other factors driving the growth of
the market.
The constraints however are overwhelming and include patent expiries such as Actelion's Tracleer (2015), and United Therapeutic's Remodulin (2014). Other blockbuster’s such as Novartis's Diovan and Exforge, Sanofi Aventis's Avapro (2012) etc are also off-patent.
The constraints however are overwhelming and include patent expiries such as Actelion's Tracleer (2015), and United Therapeutic's Remodulin (2014). Other blockbuster’s such as Novartis's Diovan and Exforge, Sanofi Aventis's Avapro (2012) etc are also off-patent.
Key Players
Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer
Ingelheim, Sanofi S.A., Astra Zeneca plc, Ranbaxy Laboratories Limited, Inc.,
Takeda Pharmaceuticals Company Limited, Pfizer Inc.
Segments:
Global anti-hypertensive drugs market has been segmented on the basis of pharmacological class, hypertension type, disease source and Region.
Regional Analysis
Global anti-hypertensive drugs market has been segmented on the basis of pharmacological class, hypertension type, disease source and Region.
Regional Analysis
Globally North America is the largest market for global
anti-hypertensive drugs. Europe is the second-largest market for global
anti-hypertensive drugs. The near future market for anti-hypertensive drugs
will be dominated by the developed regions with developing regions providing a
supporting role only. However the developing regions market particularly Asia
Pacific will be the fastest growing and is likely to be the key to the future.
Browse Complete 85 Pages Premium Research Report Enabled with Respective
Tables and Figures @ https://www.marketresearchfuture.com/reports/anti-hypertensive-drugs-market-2347
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat Of New Entrants
About US:
Market Research Future (MRFR), enable customers
to unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
No comments:
Post a Comment